Blood glucose dysregulation and cognitive outcome in ARDS survivors

Brain Injury

Volumn 24, Issue 12, 2010, Pages 1478-1484

  Hopkins, Ramona O ^a,b,c   Suchyta, Mary R ^a,b   Snow, Gregory L ^a   Jephson, Al ^a,b   Weaver, Lindell K ^a,b,d   Orme Jr , James F ^a,b,d  

^a LDS HOSPITAL   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute respiratory distress syndrome; Blood glucose; Cognitive impairments; Critical illness; Hyperglycaemia

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; COGNITIVE DEFECT; CRITICAL ILLNESS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOXEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 77958464398     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2010.506861     Document Type: Article

References (43)

1. Vanden Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001;345:1359-1367.
2. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. American Surgeon 2007;73: 454-460.
3. Baltan S. Surviving anoxia: A tale of two white matter tracts. Critical Reviews in Neurobiology 2006;18:95-103.
4. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59: 669-674.
5. Gardiner M, Smith ML, Kagstrom E, Shohami E, Siesjo BK. Influence of blood glucose concentration on brain lactate accumulation during severe hypoxia and subsequent recovery of brain energy metabolism. Journal of Cerebral Blood Flow and Metabolism 1982;2:429-438.
6. Young B, Ott L, Dempsey R, Haack D, Tibbs P. Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Annals of Surgery 1989;210: 466-472, discussion 72-73.
7. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, vander Grond J, Kappelle LJ. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-2397.
8. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism 2002;87: 978-982.
9. Vanden Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. New England Journal of Medicine 2006;354:449-461.
10. Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Critical Care 2008;12:R29.
11. Soylemez Wiener R, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA: Journal of the American Medical Association 2008;300:933-944.
12. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine 2009;360:1283-1297.
13. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, et al. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Critical Care Medicine 2008; 36:3190-3197.
14. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. New England Journal of Medicine 2005;353:1685-1693.
15. Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme Jr JF. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2005;171:340-347.
16. Weinert CR. Epidemiology of psychiatric medication use in patients recovering from critical illness at a long-term acute-care facility. Chest 2001;119:547-553.
17. Orme Jr JF, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, Crapo RO, Weaver LK. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2003;167:690-694.
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Critical Care Medicine 1985;13:818-829.
19. Oniki TA, Gardner RM. Computerized detection of arterial oxygen desaturations in an intensive care unit. Proceedings of the Annual Symposium on computer applications in medical care 1993:356-360.
20. Hopkins RO, Weaver LK, Pope D, Orme Jr JF, Bigler ED, Larson-Lohr V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1999;160:50-56.
21. Wechsler D. Wechsler Adult Intelligence Scale. In: Wechsler D, editor. Wechsler Adult Intelligance Scale. 3rd ed. San Antonio: The Psychological Corporation; 1997.
22. Wechsler D. Wechsler Memory Scale. In: Wechsler D, editor. Wechsler Memory Scale. 3rd ed. San Antonio: The Psychological Corporation; 1997.
23. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1958.
24. Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press; 1985.
25. Naugle RI, Cullum CM, Bigler ED. Introduction to clinical neuropsychology: A case book. Austin, TX: Pro-Ed; 1998.
26. Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources, Inc.; 1991.
27. Heaton RK. Comprehensive norms for an expanded Halstead-Reitan Battery: A supplement for the WAIS-R. Odessa, FL: Psychological Assessment Resources, Inc.; 1994.
28. Jackson JC, Hart RP, Gordon SM, Shintani A, Truman B, May L, Ely EW. Six-month neuropsychological outcome of medical intensive care unit patients. Critical Care Medicine 2003;31:1226-1234.
29. Newman M, Kirchner J, Phillips-Bute B, Gaver V, Grocott H, Jones R, Mark D, Reves J, Blumenthal J. Neurological Outcome Research Group, Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. New England Journal of Medicine 2001;344:395-402.
30. Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society, Series B 1996; 58:267-288.
31. Venables WN, Ripley BD. Modern Applied Statistics with S. 3rd ed. New York: Springer; 2002.
32. Duning T, vanden Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J, Lohmann H, Freise H, Ellger B. Hypoglycemia aggravates critical illness-induced neurocog-nitive dysfunction. Diabetes Care 2010;33:639-644.
33. Bruno A, Biller J, Adams Jr HP, Clarke WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) investigators. Neurology 1999;52:280-284.
34. Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial. Neurology 2001;57:1603-1610.
35. Dowdy DW, Dinglas V, Mendez-Tellez PA, Bienvenu OJ, Sevransky J, Dennison CR, Shanholtz C, Needham DM. Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury. Critical Care Medicine 2008;36:2726-2733.
36. Starr JL, Whalley LJ. Drug induced dementia. Drug Safety 1994;11:310-317.
37. Hopkins RO, Weaver LK, Chan KJ, Orme Jr JF. Quality of life, emotional, and cognitive function following acute respiratory distress syndrome. Journal of the International Neuropsychological Society 2004;10:1005-1017.
38. Jackson JC, Gordon SM, Hart RP, Hopkins RO, Ely EW. The association between delirium and cognitive decline: A review of the empirical literature. Neuropsychology Review 2004;14:87-98.
39. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005;12:255-269.
40. Jackson JC, Hopkins RO, Miller RR, Gordon SM, Wheeler AP, Thomason JWW, Ely EW. Acute respiratory distress syndrome. Sepsis, and cognitive decline: A review and case study. Southern Medical Journal 2009;102:1150-1157.
41. Jones C, Griffiths RD, Slater T, Benjamin KS, Wilson S. Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness. Intensive Care Medicine 2006;32: 923-926.
42. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008;358:125-139.
43. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, Santoro A, Rosa G. Intensive insulin therapy after severe traumatic brain injury: A randomized clinical trial. Neurocritical Care 2008;9:159-166.